Monogram Technologies Stock Surges 57% On FDA Clearance For MBôs TKA System

(RTTNews) - Monogram Technologies Inc. (MGRM) is trading at $3.67, up 57.40 percent or $1.34 during Monday's trading, after announcing that the U.S. Food and Drug Administration has granted clearance for its Monogram mBôs TKA System.

The stock opened at $2.80 and has traded between $2.80 and $4.21 so far, compared to a previous close of $2.33 on the Nasdaq. Trading volume is significantly elevated at 26.77 million shares, well above the average volume of 47,962. The stock's 52-week range is $1.53 to $4.90.

The clearance allows the AI-driven robotics company to market the device, which focuses on orthopedic surgery.